Review summary
Historical dates
August 13, 1860 – November 3, 1926Synthetic DOB
1961-08-13Index visit
2026-02-09 at age 64Synthetic MRN
HR-NI021-SYNTeaching objective: Diagnose pernicious anemia with early neurologic involvement in a slight, active woman of 64; replace B12 by injection and confirm the response on the CMID schedule; stage autoimmune gastritis by endoscopy for gastric neoplasia and neuroendocrine tumors; recognize the iron deficiency that recovery unmasks; and manage chronic low back pain from old injuries with exercise-first ACP care while checking neuropathy and fall risk.
Historical timeline
| Date | Event | Claims |
|---|---|---|
| August 13, 1860 | Born in Darke County, Ohio. | CLM-0001 |
| 1866 | Father died, at about the time she turned six. | CLM-0002 |
| October 29, 1901 | Back injured in a train collision in North Carolina. | CLM-0004 |
| November 1922 | Severely injured in an automobile accident in Florida. | CLM-0005 |
| 1925 | Moved back to Darke County, Ohio, in declining health. | CLM-0006 |
| November 3, 1926 | Died in Greenville, Ohio; pernicious anemia reported as the cause. | CLM-0007 |
Evidence claims
D = documented, R = retrospective, S = synthetic.
| Grade | Claim | Certainty | Sources |
|---|---|---|---|
| D | Annie Oakley was born Phoebe Ann Moses (also spelled Mosey) on August 13, 1860, in Darke County, Ohio, to Jacob Moses and Susan Wise Moses. | confirmed | Anderson A. Annie Oakley supports Annie Oakley supports Annie Oakley "Little Miss Sure Shot" supports |
| D | Her father died when she was six; two sources give pneumonia as the cause, and the Garst Museum says he died from exposure to winter weather. Her mother was left to support a large family. Pneumonia after winter exposure, as reported; no further detail is recorded. |
confirmed | Anderson A. Annie Oakley supports Annie Oakley supports Annie Oakley "Little Miss Sure Shot" supports |
| D | She became a celebrated exhibition sharpshooter who toured with a Wild West show in the United States and Europe, and in later years she gave exhibitions and taught women to shoot. Documents her occupation; used for the synthetic social history. |
confirmed | Anderson A. Annie Oakley supports Annie Oakley "Little Miss Sure Shot" supports |
| D | On October 29, 1901, the show's train collided head-on with another train in North Carolina; Oakley's back was injured, and the accident ended her touring with the show. The back injury is documented; its nature, and any treatment, are reported inconsistently and are not used. |
confirmed | Annie Oakley supports Anderson A. Annie Oakley supports Annie Oakley supports |
| D | Late in 1922 she was severely injured in an automobile accident in Florida, reported as fractures of the hip and ankle, after which she had to wear a brace on her leg; her recovery took more than a year. The accident and long recovery are documented in two sources; the fractures and brace are reported in one. |
probable | Annie Oakley supports Annie Oakley supports Anderson A. Annie Oakley supports |
| D | Her health declined in the years after the accident, and in 1925 she moved back to Darke County, Ohio. | confirmed | Anderson A. Annie Oakley supports Annie Oakley supports Annie Oakley "Little Miss Sure Shot" supports |
| D | Oakley died on November 3, 1926, in Greenville, Ohio, aged 66; the Garst Museum and HistoryNet give pernicious anemia as the cause of death. The documented anchor for the synthetic pernicious anemia episode. How the diagnosis was made in 1926 is not recorded in the cited sources. Record the death as a fact without graphic detail. |
confirmed | Annie Oakley "Little Miss Sure Shot" supports Annie Oakley supports Anderson A. Annie Oakley supports Annie Oakley supports |
Modern synthetic problem list
| Grade | Problem | Clinical status | Verification | Placement | Historical claims |
|---|---|---|---|---|---|
| S | Pernicious anemia with B12 deficiency neuropathy (reduced vibration and proprioception in the feet); synthetic modern diagnosis linked to the documented 1926 cause of death | active | confirmed | both_with_link | CLM-0007 |
| S | Chronic low back pain, mechanical, without radiculopathy; synthetic modern problem linked to the documented 1901 train collision and 1922 automobile accident | active | confirmed | both_with_link | CLM-0004, CLM-0005 |
| S | Autoimmune atrophic gastritis, corpus-predominant, with linear ECL-cell hyperplasia; no neuroendocrine tumor, dysplasia, or cancer; H. pylori negative | active | confirmed | active | CLM-0007 |
| S | Iron deficiency without anemia, unmasked by red cell recovery and reduced iron absorption in atrophic gastritis | active | confirmed | active | |
| S | Acute uncomplicated cystitis, resolved with nitrofurantoin | resolved | confirmed | active |
Synthetic outcome measures
| Grade | Date | Measure | Result | Coding |
|---|---|---|---|---|
| S | 2026-02-09 | Hemoglobin [Mass/volume] in Blood | 8.9 g/dL (low) Reference 11.6-15 g/dL |
http://loinc.org · 718-7 |
| S | 2026-02-09 | MCV [Entitic mean volume] in Red Blood Cells by Automated count | 114 fL (high) Reference 80-100 fL |
http://loinc.org · 787-2 |
| S | 2026-02-09 | Leukocytes [#/volume] in Blood by Automated count | 3.6 10*3/uL (low) Reference 4-11 10*3/uL |
http://loinc.org · 6690-2 |
| S | 2026-02-09 | Platelets [#/volume] in Blood by Automated count | 128 10*3/uL (low) Reference 150-400 10*3/uL |
http://loinc.org · 777-3 |
| S | 2026-02-09 | Reticulocytes/Erythrocytes in Blood by Automated count | 0.6% Reference 0.5-2.5% |
http://loinc.org · 17849-1 |
| S | 2026-02-09 | Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma | 96 pg/mL (low) Reference 232-1245 pg/mL |
http://loinc.org · 2132-9 |
| S | 2026-02-09 | Folate [Mass/volume] in Serum or Plasma | 11.8 ng/mL Reference >=5.9 ng/mL |
http://loinc.org · 2284-8 |
| S | 2026-02-09 | Methylmalonate [Moles/volume] in Serum or Plasma | 2.1 umol/L (high) Reference <=0.4 umol/L |
http://loinc.org · 13964-2 |
| S | 2026-02-09 | Intrinsic factor Ab [Units/volume] in Serum | 38.4 [arb'U]/mL (high) Reference <=1.2 [arb'U]/mL |
http://loinc.org · 11564-2 |
| S | 2026-02-09 | Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma | 612 U/L (high) Reference 120-246 U/L |
http://loinc.org · 2532-0 |
| S | 2026-02-09 | Bilirubin.total [Mass/volume] in Serum or Plasma | 1.6 mg/dL (high) Reference 0.1-1.2 mg/dL |
http://loinc.org · 1975-2 |
| S | 2026-02-09 | Ferritin [Mass/volume] in Serum or Plasma | 52 ng/mL Reference 30-400 ng/mL |
http://loinc.org · 2276-4 |
| S | 2026-02-09 | Iron saturation [Mass Fraction] in Serum or Plasma | 34% Reference 20-50% |
http://loinc.org · 2502-3 |
| S | 2026-02-09 | Thyrotropin [Units/volume] in Serum or Plasma | 2.1 mIU/L Reference 0.45-4.5 mIU/L |
http://loinc.org · 3016-3 |
| S | 2026-02-09 | Potassium [Moles/volume] in Serum or Plasma | 4.1 mmol/L Reference 3.5-5.1 mmol/L |
http://loinc.org · 2823-3 |
| S | 2026-02-09 | Creatinine [Mass/volume] in Serum or Plasma | 0.72 mg/dL Reference 0.59-1.04 mg/dL |
http://loinc.org · 2160-0 |
| S | 2026-02-09 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 93 mL/min/1.73 m² Reference >=60 mL/min/1.73 m² |
http://loinc.org · 98979-8 |
| S | 2026-02-09 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 1 | http://loinc.org · 55758-7 |
| S | 2026-02-09 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 5 | http://loinc.org · 72514-3 |
| S | 2026-02-09 | Oswestry disability index score ODI | 28 | http://loinc.org · 97909-6 |
| S | 2026-02-17 | Hemoglobin [Mass/volume] in Blood | 9.6 g/dL (low) Reference 11.6-15 g/dL |
http://loinc.org · 718-7 |
| S | 2026-02-17 | MCV [Entitic mean volume] in Red Blood Cells by Automated count | 110 fL (high) Reference 80-100 fL |
http://loinc.org · 787-2 |
| S | 2026-02-17 | Leukocytes [#/volume] in Blood by Automated count | 4.4 10*3/uL Reference 4-11 10*3/uL |
http://loinc.org · 6690-2 |
| S | 2026-02-17 | Platelets [#/volume] in Blood by Automated count | 196 10*3/uL Reference 150-400 10*3/uL |
http://loinc.org · 777-3 |
| S | 2026-02-17 | Reticulocytes/Erythrocytes in Blood by Automated count | 6.8% (high) Reference 0.5-2.5% |
http://loinc.org · 17849-1 |
| S | 2026-02-17 | Potassium [Moles/volume] in Serum or Plasma | 3.7 mmol/L Reference 3.5-5.1 mmol/L |
http://loinc.org · 2823-3 |
| S | 2026-04-06 | Hemoglobin [Mass/volume] in Blood | 12.3 g/dL Reference 11.6-15 g/dL |
http://loinc.org · 718-7 |
| S | 2026-04-06 | MCV [Entitic mean volume] in Red Blood Cells by Automated count | 96 fL Reference 80-100 fL |
http://loinc.org · 787-2 |
| S | 2026-04-06 | Leukocytes [#/volume] in Blood by Automated count | 5.4 10*3/uL Reference 4-11 10*3/uL |
http://loinc.org · 6690-2 |
| S | 2026-04-06 | Platelets [#/volume] in Blood by Automated count | 245 10*3/uL Reference 150-400 10*3/uL |
http://loinc.org · 777-3 |
| S | 2026-04-06 | Methylmalonate [Moles/volume] in Serum or Plasma | 0.28 umol/L Reference <=0.4 umol/L |
http://loinc.org · 13964-2 |
| S | 2026-04-06 | Ferritin [Mass/volume] in Serum or Plasma | 14 ng/mL (low) Reference 30-400 ng/mL |
http://loinc.org · 2276-4 |
| S | 2026-04-06 | Iron saturation [Mass Fraction] in Serum or Plasma | 11% (low) Reference 20-50% |
http://loinc.org · 2502-3 |
| S | 2026-04-06 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | http://loinc.org · 55758-7 |
| S | 2026-04-06 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 4 | http://loinc.org · 72514-3 |
| S | 2026-04-06 | Oswestry disability index score ODI | 22 | http://loinc.org · 97909-6 |
| S | 2026-07-06 | Hemoglobin [Mass/volume] in Blood | 13.1 g/dL Reference 11.6-15 g/dL |
http://loinc.org · 718-7 |
| S | 2026-07-06 | MCV [Entitic mean volume] in Red Blood Cells by Automated count | 92 fL Reference 80-100 fL |
http://loinc.org · 787-2 |
| S | 2026-07-06 | Leukocytes [#/volume] in Blood by Automated count | 5.8 10*3/uL Reference 4-11 10*3/uL |
http://loinc.org · 6690-2 |
| S | 2026-07-06 | Platelets [#/volume] in Blood by Automated count | 262 10*3/uL Reference 150-400 10*3/uL |
http://loinc.org · 777-3 |
| S | 2026-07-06 | Ferritin [Mass/volume] in Serum or Plasma | 48 ng/mL Reference 30-400 ng/mL |
http://loinc.org · 2276-4 |
| S | 2026-07-06 | Iron saturation [Mass Fraction] in Serum or Plasma | 24% Reference 20-50% |
http://loinc.org · 2502-3 |
| S | 2026-07-06 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 3 | http://loinc.org · 72514-3 |
| S | 2026-07-06 | Oswestry disability index score ODI | 16 | http://loinc.org · 97909-6 |
| S | 2026-07-27 | Cholesterol [Mass/volume] in Serum or Plasma | 204 mg/dL (high) Reference <=199 mg/dL |
http://loinc.org · 2093-3 |
| S | 2026-07-27 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 74 mg/dL Reference >=50 mg/dL |
http://loinc.org · 2085-9 |
| S | 2026-07-27 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 112 mg/dL (high) Reference <=99 mg/dL |
http://loinc.org · 13457-7 |
| S | 2026-07-27 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | http://loinc.org · 55758-7 |
| S | 2026-07-27 | Total score [AUDIT-C] | 1 | http://loinc.org · 75626-2 |
Synthetic vital signs
| Date | Measure | Result | LOINC | Grade |
|---|---|---|---|---|
| 2026-02-09 | Body height | 152 cm | 8302-2 | S |
| 2026-02-09 | Body weight | 46.2 kg | 29463-7 | S |
| 2026-02-09 | Body mass index (BMI) [Ratio] | 20 kg/m2 | 39156-5 | S |
| 2026-02-09 | Systolic blood pressure | 118 mm[Hg] | 8480-6 | S |
| 2026-02-09 | Diastolic blood pressure | 64 mm[Hg] | 8462-4 | S |
| 2026-02-09 | Heart rate | 98 /min | 8867-4 | S |
| 2026-02-09 | Respiratory rate | 18 /min | 9279-1 | S |
| 2026-02-09 | Body temperature | 36.6 Cel | 8310-5 | S |
| 2026-02-09 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 2026-02-17 | Body height | 152 cm | 8302-2 | S |
| 2026-02-17 | Body weight | 46.4 kg | 29463-7 | S |
| 2026-02-17 | Body mass index (BMI) [Ratio] | 20.1 kg/m2 | 39156-5 | S |
| 2026-02-17 | Systolic blood pressure | 116 mm[Hg] | 8480-6 | S |
| 2026-02-17 | Diastolic blood pressure | 66 mm[Hg] | 8462-4 | S |
| 2026-02-17 | Heart rate | 90 /min | 8867-4 | S |
| 2026-02-17 | Respiratory rate | 16 /min | 9279-1 | S |
| 2026-02-17 | Body temperature | 36.7 Cel | 8310-5 | S |
| 2026-02-17 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 % | 59408-5 | S |
| 2026-04-06 | Body height | 152 cm | 8302-2 | S |
| 2026-04-06 | Body weight | 47.3 kg | 29463-7 | S |
| 2026-04-06 | Body mass index (BMI) [Ratio] | 20.5 kg/m2 | 39156-5 | S |
| 2026-04-06 | Systolic blood pressure | 120 mm[Hg] | 8480-6 | S |
| 2026-04-06 | Diastolic blood pressure | 70 mm[Hg] | 8462-4 | S |
| 2026-04-06 | Heart rate | 76 /min | 8867-4 | S |
| 2026-04-06 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-04-06 | Body temperature | 36.6 Cel | 8310-5 | S |
| 2026-04-06 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 % | 59408-5 | S |
| 2026-07-06 | Body height | 152 cm | 8302-2 | S |
| 2026-07-06 | Body weight | 47.8 kg | 29463-7 | S |
| 2026-07-06 | Body mass index (BMI) [Ratio] | 20.7 kg/m2 | 39156-5 | S |
| 2026-07-06 | Systolic blood pressure | 122 mm[Hg] | 8480-6 | S |
| 2026-07-06 | Diastolic blood pressure | 72 mm[Hg] | 8462-4 | S |
| 2026-07-06 | Heart rate | 72 /min | 8867-4 | S |
| 2026-07-06 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-07-06 | Body temperature | 36.7 Cel | 8310-5 | S |
| 2026-07-06 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 % | 59408-5 | S |
| 2026-05-26 | Body height | 152 cm | 8302-2 | S |
| 2026-05-26 | Body weight | 47.5 kg | 29463-7 | S |
| 2026-05-26 | Body mass index (BMI) [Ratio] | 20.6 kg/m2 | 39156-5 | S |
| 2026-05-26 | Systolic blood pressure | 124 mm[Hg] | 8480-6 | S |
| 2026-05-26 | Diastolic blood pressure | 72 mm[Hg] | 8462-4 | S |
| 2026-05-26 | Heart rate | 80 /min | 8867-4 | S |
| 2026-05-26 | Respiratory rate | 16 /min | 9279-1 | S |
| 2026-05-26 | Body temperature | 36.9 Cel | 8310-5 | S |
| 2026-05-26 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 % | 59408-5 | S |
| 2026-07-27 | Body height | 152 cm | 8302-2 | S |
| 2026-07-27 | Body weight | 47.9 kg | 29463-7 | S |
| 2026-07-27 | Body mass index (BMI) [Ratio] | 20.7 kg/m2 | 39156-5 | S |
| 2026-07-27 | Systolic blood pressure | 120 mm[Hg] | 8480-6 | S |
| 2026-07-27 | Diastolic blood pressure | 70 mm[Hg] | 8462-4 | S |
| 2026-07-27 | Heart rate | 70 /min | 8867-4 | S |
| 2026-07-27 | Respiratory rate | 14 /min | 9279-1 | S |
| 2026-07-27 | Body temperature | 36.6 Cel | 8310-5 | S |
| 2026-07-27 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 % | 59408-5 | S |
Social, functional, and mental status
Social history
- S Occupation: retired exhibition shooter who still shoots trap outdoors and teaches shooting classes for women
- S Never smoker; a glass of wine on occasion; eats meat and dairy daily; no vegetarian or restrictive diet
- S Married; lives in a single-story house in a small Ohio town; drives
- S Supports: a close family nearby and her students at the shooting club
Functional status
- S Independent in all activities of daily living; breathless on one flight of stairs; unsteady in the dark; back pain limits standing at the range to about 20 minutes at intake
- S Back to teaching full classes and walking a mile a day by the five-month review
Mental status
- S Alert, precise, and cheerful; determined to keep teaching
- S Mood euthymic; PHQ-2 negative; memory and attention intact
Allergies and medications
Allergies
- S No known allergy
Medications
- S Cyanocobalamin 1000 micrograms (1 mL) intramuscular injection once daily for seven days
- S Cyanocobalamin 1000 micrograms (1 mL) intramuscular injection once weekly for four weeks
- S Cyanocobalamin 1000 micrograms (1 mL) intramuscular injection once a month, lifelong
- S Ferrous sulfate 325 mg oral tablet (65 mg elemental iron), one tablet by mouth every other day with orange juice
- S Naproxen sodium 220 mg oral tablet, one tablet by mouth with food up to twice daily as needed for back pain flares
- S Nitrofurantoin monohydrate/macrocrystals 100 mg oral capsule, one capsule by mouth twice daily with food for five days
Procedures and immunizations
Procedures
- S Physical therapy program for chronic low back pain: eight weekly sessions of supervised exercise, core and hip strengthening, and balance training, with a home program
- S Esophagogastroduodenoscopy with biopsies of the gastric body, antrum, and incisura in separate jars, and of the duodenum: pale, thin corpus mucosa with visible vessels and loss of folds; two 3 mm body polyps removed (hyperplastic). Histology: corpus-predominant atrophic gastritis with intestinal metaplasia and linear ECL-cell hyperplasia, antrum spared; no neuroendocrine tumor, dysplasia, or cancer; H. pylori negative; duodenal villi normal
- S Colonoscopy to the cecum for iron deficiency: a few sigmoid diverticula; no polyps, tumor, or bleeding source
Immunizations
- S 2025-10-20: Influenza vaccine, 2025-2026 season
- S 2023-05-15: Recombinant zoster vaccine, two-dose series completed
- S 2021-06-07: Tdap vaccine
- S 2026-07-27: Pneumococcal conjugate vaccine PCV20
Past medical history
True biography with historical dates; not part of the synthetic care timeline.
- D October 29, 1901: Back injured in a head-on train collision in North Carolina; it ended her touring with the show (CLM-0004)
- D November 1922: Severe injuries in an automobile accident in Florida, reported as fractures of the hip and ankle, with a leg brace afterward and more than a year of recovery (CLM-0005)
Family history
- D father: Died when she was six, of pneumonia after exposure to winter weather, as reported
- D mother: Health and cause of death not recorded in the cited sources
Care-plan goals
| Goal | Target date | Status | Outcome |
|---|---|---|---|
| Normal hemoglobin and MCV within eight weeks of starting B12 replacement | 2026-04-06 | completed | Hemoglobin 12.3 g/dL and MCV 96 fL at eight weeks |
| Stop the progression of neuropathy and recover balance, with no falls | 2026-07-06 | completed | Paresthesia gone, Romberg negative, vibration mildly reduced at the great toes only; no falls |
| Reduce back pain to 3 of 10 or less and the Oswestry score below 20 percent by the five-month review | 2026-07-06 | completed | Pain 3 of 10 and Oswestry 16 percent |
| Return to teaching full shooting classes | 2026-07-06 | completed | Teaching two full classes a week |
Interventions
| Intervention | Status | Guideline |
|---|---|---|
| Intramuscular cyanocobalamin 1000 micrograms daily for one week, weekly for four weeks, then monthly for life | completed | GL-AAFP-B12-2017, GL-BSH-B12-2014, GL-CMID-2026 |
| Hematology consultation to confirm pernicious anemia, review the cytopenias and neurologic findings, and advise on replacement and gastric risk | completed | GL-BSH-B12-2014, GL-AGA-AG-2021 |
| Monitor the response on the CMID schedule: reticulocytes at one week, potassium during early replacement, blood count and MMA at eight weeks, and a neurologic examination at each visit; no routine repeat B12 level | completed | GL-CMID-2026, GL-BSH-B12-2014 |
| Upper endoscopy with topographic gastric biopsies to confirm autoimmune gastritis and look for neuroendocrine tumors and gastric neoplasia, with H. pylori testing and TSH for autoimmune thyroid disease | completed | GL-AGA-AG-2021 |
| Treat iron deficiency unmasked by recovery with alternate-day oral iron, and complete the GI evaluation with colonoscopy | completed | GL-AGA-IDA-2020, GL-CMID-2026 |
| Chronic low back pain: eight weeks of supervised exercise therapy and a home program, heat, and tai chi; an NSAID as needed once the platelet count is normal; no imaging without red flags | completed | GL-ACP-LBP-2017 |
| Fall prevention: neuropathy and gait checks at each visit, strength and balance exercise, night lights, and home-safety review | completed | GL-CMID-2026, GL-USPSTF-FALLS-2024 |
Planned encounters
- 2026-02-09 — Primary care visit for four months of tiredness, breathlessness, sore tongue, and tingling feet, with long-standing low back pain (ENC-001)
- 2026-02-17 — One-week review after starting vitamin B12 injections, with hematology consultation (ENC-002)
- 2026-04-06 — Eight-week pernicious anemia review, endoscopy results, and back pain review (ENC-003)
- 2026-05-26 — Same-day sick visit for burning on urination (ENC-005, unscheduled)
- 2026-07-06 — Five-month pernicious anemia, iron, neuropathy, and back pain review (ENC-004)
- 2026-07-27 — Adult preventive visit (ENC-006)
Supporting documents
- History and physical
- Progress note 01
- Progress note 02 — Focused Visit (Follow-up)
- Progress note 03 — Focused Visit (Follow-up)
- Progress note 04 — Sick Visit
- Progress note 05 — Focused Visit (Care-plan review)
- Progress note 06 — Preventive Visit
- Hematology referral
- Hematology consultation
- Patient care plan
- Teaching note
- Provenance CSV
C-CDA note documents
Each link opens a readable copy; the XML beside it is the exchange file.
- History and physical (XML)
- Progress note 01 (XML)
- Progress note 02 — Focused Visit (Follow-up) (XML)
- Progress note 03 — Focused Visit (Follow-up) (XML)
- Progress note 04 — Sick Visit (XML)
- Progress note 05 — Focused Visit (Care-plan review) (XML)
- Progress note 06 — Preventive Visit (XML)
- Hematology referral (XML)
- Hematology consultation (XML)
Sources
| ID | Source | Publisher | Type |
|---|---|---|---|
| SRC-0001 | Anderson A. Annie Oakley | National Women's History Museum | other |
| SRC-0002 | Annie Oakley | Buffalo Bill Center of the West | other |
| SRC-0003 | Annie Oakley "Little Miss Sure Shot" | Garst Museum (Darke County Historical Society), Greenville, Ohio | other |
| SRC-0004 | Annie Oakley | HistoryNet | other |
| SRC-0005 | HISTMED Master Roster v3 | The Human Record project | other |
Review status
| Review | Status | Notes |
|---|---|---|
| schema validation | not_started | Run scripts/build.ps1 -Conformance. |
| clinical review | not_started | Awaiting clinician review; check the B12 regimen, the endoscopy surveillance interval, and the back pain plan. |
| provenance review | not_started | National Women's History Museum, Buffalo Bill Center of the West, Garst Museum, and HistoryNet pages logged; the hip and ankle fractures are single-source and marked probable; the lead-exposure speculation is not used. |
| safe messaging review | not_started | No behavioral-health content; death recorded without graphic detail. |
Comments and corrections
Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.
Comments appear on the online version of this page.